Charles River Laboratories | CRL - Current Liabilities


Charles River Laboratories reported $1.12B in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Agilent USD 2.35B 455M Sep/2025
Align Technology USD 1.92B 46.45M Dec/2025
Bio-Rad Laboratories USD 517M 5.3M Dec/2025
Bruker USD 1.28B 11.1M Dec/2025
Cardinal Health USD 43.31B 3.05B Dec/2025
Charles River Laboratories USD 1.12B 1.57M Dec/2025
Cigna USD 56.45B 326M Sep/2025
Concord Medical Services Hldg CNY 1.34B 214.68M Jun/2023
CVS Health USD 88.69B 4B Dec/2025
Danaher USD 6.81B 483M Dec/2025
Dentsply International USD 1.4B 239M Sep/2025
Elevance Health USD 41.04B 157M Dec/2025
Galapagos EUR 366.56M 36.39M Sep/2025
Hologic USD 951.3M 25.9M Dec/2025
Humana USD 16.35B 166M Dec/2025
Illumina USD 1.59B 377M Dec/2025
Incyte USD 1.52B 176.44M Dec/2025
Intrexon USD 23.02M 38K Jun/2024
IQVIA Holdings USD 8.34B 170M Dec/2025
Laboratory Of America USD 2.82B 194.3M Dec/2025
Lonza CHF 3.58B 970M Dec/2024
McKesson USD 68.13B 100M Dec/2025
Merck EUR 8.64B 1.22B Sep/2025
Mettler Toledo International USD 1.2B 5.99M Dec/2025
Novartis USD 32B 286M Sep/2025
Pfizer USD 36.6B 1.13B Sep/2025
Quest Diagnostics USD 2.28B 144M Dec/2025
Revvity USD 1.33B 108.5M Dec/2025
Thermo Fisher Scientific USD 15.19B 301M Dec/2025
United Therapeutics USD 546.3M 19.2M Sep/2025
UnitedHealth USD 115.53B 4.74B Sep/2025
Veradigm USD 253.09M 3.24M Sep/2022
Waters USD 1.24B 11.8M Dec/2025
West Pharmaceutical Services USD 654.9M 19.5M Dec/2025